Abstract: The present invention encompasses methods of treating triple negative breast cancer and/or ovarian cancer using therapeutically effective amounts of compounds represented by the structure of formula I.
Type:
Application
Filed:
May 15, 2019
Publication date:
December 26, 2019
Applicants:
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, VERU INC
Inventors:
Wei LI, Duane D. MILLER, Shanshan DENG, Raya KRUTILINA, Tiffany N. SEAGROVES, Junming YUE, Guannan ZHAO, Wang QINGHUI, Mitchell S. STEINER